Dyne Therapeutics, Inc.
Total Trades
132
Buys
3
Sells
105
Largest Trade
N/A
Insiders
14
Institutional Funds
173
Inst. Value
$1M+
Activist Filings
49
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna | Chief Commercial O… | SELL | $1K–$15K | 148 | $14.90 | Mar 6, 2026 |
| Kerr Douglas | Chief Medical Offi… | SELL | $1K–$15K | 904 | $14.90 | Mar 6, 2026 |
| Cox John | CEO & President | SELL | $15K–$50K | 3K | $14.90 | Mar 6, 2026 |
| Cox John | CEO & President | SELL | $50K–$100K | 3K | $20.72 | Dec 5, 2025 |
| Kerr Douglas | Chief Medical Offi… | SELL | $15K–$50K | 880 | $20.72 | Dec 5, 2025 |
| Friedl-Naderer Johanna | Chief Commercial O… | SELL | $1K–$15K | 144 | $20.72 | Dec 5, 2025 |
| Cox John | CEO & President | SELL | $15K–$50K | 3K | $13.41 | Sep 9, 2025 |
| Friedl-Naderer Johanna | Chief Commercial O… | SELL | $1K–$15K | 1K | $13.29 | Sep 8, 2025 |
| Kerr Douglas | Chief Medical Offi… | SELL | $50K–$100K | 4K | $13.30 | Sep 8, 2025 |
| Cox John | CEO & President | BUY | $500K+ | 100K | $9.11 | Jul 15, 2025 |
| Cox John | CEO & President | SELL | $50K–$100K | 4K | $13.35 | Jun 6, 2025 |
| Kerr Douglas | Chief Medical Offi… | SELL | $15K–$50K | 1K | $13.35 | Jun 6, 2025 |
| Friedl-Naderer Johanna | Chief Commercial O… | SELL | $1K–$15K | 146 | $13.35 | Jun 6, 2025 |
| Friedl-Naderer Johanna | Chief Commercial O… | SELL | $1K–$15K | 143 | $12.12 | Mar 13, 2025 |
| Scalzo Richard William | SVP | SELL | $15K–$50K | 1K | $11.38 | Mar 13, 2025 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $15K–$50K | 2K | $11.38 | Mar 13, 2025 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $15K–$50K | 3K | $13.95 | Feb 25, 2025 |
| Kersten Dirk | Director | SELL | $1M+ | 111K | $29.50 | Dec 4, 2024 |
| Incerti Carlo | Director | SELL | $100K–$500K | 17K | $28.73 | Nov 19, 2024 |
| Incerti Carlo | Director | EXERCISE | $100K–$500K | 17K | $8.69 | Nov 19, 2024 |
| Rhodes Jason P | Director | SELL | $15K–$50K | 782 | $33.10 | Nov 18, 2024 |
| Scalzo Richard William | SVP | SELL | $50K–$100K | 3K | $28.20 | Nov 18, 2024 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $50K–$100K | 3K | $28.20 | Nov 18, 2024 |
| Kersten Dirk | Director | SELL | $500K+ | 20K | $34.14 | Nov 15, 2024 |
| Kersten Dirk | Director | SELL | $100K–$500K | 14K | $35.16 | Oct 22, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 37K | $35.29 | Oct 18, 2024 |
| Kersten Dirk | Director | SELL | $100K–$500K | 5K | $35.13 | Oct 7, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 30K | $35.32 | Oct 3, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 31K | $35.50 | Oct 1, 2024 |
| Kersten Dirk | Director | SELL | $100K–$500K | 4K | $35.14 | Sep 27, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 120K | $36.07 | Sep 24, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 134K | $45.03 | Aug 30, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 155K | $44.87 | Aug 28, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 180K | $46.02 | Aug 26, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 223K | $46.61 | Aug 22, 2024 |
| Scalzo Richard William | SVP | SELL | $100K–$500K | 3K | $45.12 | Aug 20, 2024 |
| McNeill Jonathan | Chief Business Off… | SELL | $100K–$500K | 3K | $45.12 | Aug 20, 2024 |
| Farwell Wildon | Chief Medical Offi… | SELL | $100K–$500K | 2K | $45.12 | Aug 20, 2024 |
| HIGH SUSANNA GATTI | COO | SELL | $100K–$500K | 3K | $45.12 | Aug 20, 2024 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $100K–$500K | 3K | $45.12 | Aug 20, 2024 |
| Kersten Dirk | Director | SELL | $1M+ | 249K | $45.48 | Aug 20, 2024 |
| HIGH SUSANNA GATTI | COO | EXERCISE | $100K–$500K | 40K | $5.54 | Jun 25, 2024 |
| HIGH SUSANNA GATTI | COO | SELL | $1M+ | 40K | $35.09 | Jun 25, 2024 |
| HIGH SUSANNA GATTI | COO | EXERCISE | $100K–$500K | 40K | $5.54 | Jun 14, 2024 |
| HIGH SUSANNA GATTI | COO | SELL | $1M+ | 40K | $33.35 | Jun 14, 2024 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $50K–$100K | 2K | $31.34 | Jun 11, 2024 |
| Farwell Wildon | Chief Medical Offi… | SELL | $50K–$100K | 3K | $31.27 | Jun 11, 2024 |
| HIGH SUSANNA GATTI | COO | SELL | $1M+ | 85K | $30.30 | Jun 11, 2024 |
| HIGH SUSANNA GATTI | COO | EXERCISE | $100K–$500K | 80K | $5.54 | Jun 11, 2024 |
| McNeill Jonathan | Chief Business Off… | SELL | $50K–$100K | 2K | $31.34 | Jun 11, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 173 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 9.1M | $1M+ | SH |
| STATE STREET CORP | 6.7M | $1M+ | SH |
| Siren, L.L.C. | 3.5M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 3.5M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 3.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8M | $1M+ | SH |
| Deep Track Capital, LP | 2.6M | $1M+ | SH |
| Vivo Capital, LLC | 2.6M | $1M+ | SH |
| Sofinnova Investments, Inc. | 2.3M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 2.2M | $1M+ | SH |
| VR Adviser, LLC | 2.2M | $1M+ | SH |
| BRAIDWELL LP | 1.5M | $1M+ | SH |
| Palo Alto Investors LP | 1.5M | $1M+ | SH |
| MPM BioImpact LLC | 1.4M | $1M+ | SH |
| Logos Global Management LP | 1.3M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $1M+ | SH |
| Aberdeen Group plc | 1.1M | $1M+ | SH |
| Candriam S.C.A. | 1.1M | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 701K | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 680K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
T. Rowe Price Investment Management, Inc.
SC 13G/A · Mar 6, 2026
16.2%
26.6M shares
SC 13G/A · Feb 17, 2026
8.5%
13.9M shares
T. Rowe Price Investment Management, Inc.
SC 13G · Jan 8, 2026
10.7%
17.5M shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 14, 2025
10.4%
14.7M shares
SC 13G/A · Nov 13, 2025
4.0%
5.7M shares
SC 13G/A · Aug 7, 2025
10.1%
14.4M shares
SC 13G/A · May 15, 2025
8.5%
9.7M shares
Point72 Asset Management, L.P.
SC 13G/A · May 15, 2025
1.5%
1.7M shares
SC 13G/A · May 15, 2025
4.8%
5.4M shares
SC 13G/A · May 15, 2025
1.5%
1.7M shares
SC 13G/A · May 14, 2025
9.2%
10.4M shares
SC 13G/A · May 12, 2025
4.6%
5.2M shares
SC 13G/A · Apr 17, 2025
5.8%
6.6M shares
SC 13G/A · Feb 14, 2025
7.3%
7.4M shares
SC 13G/A · Feb 14, 2025
5.1%
5.2M shares
SC 13G/A · Feb 12, 2025
7.9%
8.0M shares
Point72 Asset Management, L.P.
SC 13G · Feb 3, 2025
5.1%
5.2M shares
SC 13G/A · Nov 14, 2024
6.4%
6.4M shares
SC 13G/A · Nov 14, 2024
5.7%
5.7M shares
SC 13G/A · Nov 14, 2024
2.9%
6 shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Nov 14, 2024
6.8%
6.8M shares
SC 13G/A · Nov 14, 2024
3.3%
3.3M shares
SC 13G/A · Nov 14, 2024
5.8%
5.8M shares
SC 13G · Nov 14, 2024
6.8%
6.8M shares
SC 13G/A · Nov 12, 2024
6.8%
6.9M shares
SC 13G · Nov 12, 2024
9.0%
9.0M shares
SC 13G/A · Nov 8, 2024
7.8%
7.8M shares
SC 13G/A · Nov 4, 2024
6.8%
6.9M shares
SC 13G/A · Oct 22, 2024
7.8%
7.8M shares
SC 13G · Apr 4, 2024
6.4%
5.2M shares
SC 13G/A · Feb 14, 2024
5.0%
6 shares
SC 13G/A · Feb 14, 2024
3.3%
2.0M shares
SC 13G/A · Feb 12, 2024
4.0%
3.2M shares
SC 13G · Jan 29, 2024
6.2%
3.8M shares
SC 13G · Jan 19, 2024
5.5%
4.5M shares
SC 13G/A · Jan 19, 2024
3.3%
2.0M shares
SC 13G/A · Feb 14, 2023
14.1%
7.3M shares
SC 13G/A · Feb 14, 2023
4.1%
2.1M shares
SC 13G/A · Feb 14, 2023
5.2%
2.7M shares
SC 13G/A · Feb 14, 2023
5.6%
6 shares
SC 13D/A · Feb 10, 2023
4.2%
2.2M shares
SC 13G/A · Feb 9, 2023
8.9%
4.6M shares
SC 13G/A · Nov 14, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
5.4%
2.8M shares
SC 13G/A · Feb 14, 2022
5.7%
3.0M shares
SC 13G/A · Feb 14, 2022
5.5%
6 shares
SC 13G/A · Feb 11, 2022
14.2%
7.3M shares
SC 13G · Jan 20, 2022
5.5%
2.8M shares